12/26
04:10 pm
qlgn
Form 8-K Qualigen Therapeutics, For: Dec 23
Neutral
Report
Form 8-K Qualigen Therapeutics, For: Dec 23
12/20
06:03 am
qlgn
Form EFFECT Qualigen Therapeutics,
Low
Report
Form EFFECT Qualigen Therapeutics,
12/10
02:27 pm
qlgn
Form S-1 Qualigen Therapeutics,
Medium
Report
Form S-1 Qualigen Therapeutics,
11/22
05:29 pm
qlgn
Form D Qualigen Therapeutics,
Medium
Report
Form D Qualigen Therapeutics,
11/21
05:10 pm
qlgn
Form 8-K/A Qualigen Therapeutics, For: Nov 07
Medium
Report
Form 8-K/A Qualigen Therapeutics, For: Nov 07
11/21
04:10 pm
qlgn
Form 8-K Qualigen Therapeutics, For: Nov 18
Medium
Report
Form 8-K Qualigen Therapeutics, For: Nov 18
11/15
04:06 pm
qlgn
Form 3 Qualigen Therapeutics, For: Nov 07 Filed by: Bensler Graydon
Low
Report
Form 3 Qualigen Therapeutics, For: Nov 07 Filed by: Bensler Graydon
11/14
04:26 pm
qlgn
Form 10-Q Qualigen Therapeutics, For: Sep 30
High
Report
Form 10-Q Qualigen Therapeutics, For: Sep 30
11/13
05:11 pm
qlgn
Form 8-K Qualigen Therapeutics, For: Nov 12
Low
Report
Form 8-K Qualigen Therapeutics, For: Nov 12
11/8
05:25 pm
qlgn
Form 8-K Qualigen Therapeutics, For: Nov 05
High
Report
Form 8-K Qualigen Therapeutics, For: Nov 05
11/1
04:56 pm
qlgn
Form 8-K Qualigen Therapeutics, For: Oct 25
Low
Report
Form 8-K Qualigen Therapeutics, For: Oct 25
10/29
04:06 pm
qlgn
Form 8-K Qualigen Therapeutics, For: Oct 25
Low
Report
Form 8-K Qualigen Therapeutics, For: Oct 25
10/24
05:06 pm
qlgn
Form S-1 Qualigen Therapeutics,
Medium
Report
Form S-1 Qualigen Therapeutics,
10/22
04:36 pm
qlgn
Form 8-K Qualigen Therapeutics, For: Oct 18
Low
Report
Form 8-K Qualigen Therapeutics, For: Oct 18
10/17
04:06 pm
qlgn
Form 3 Qualigen Therapeutics, For: Oct 08 Filed by: Braeden Lichti
Low
Report
Form 3 Qualigen Therapeutics, For: Oct 08 Filed by: Braeden Lichti
10/9
04:10 pm
qlgn
Form DEFA14A Qualigen Therapeutics,
Medium
Report
Form DEFA14A Qualigen Therapeutics,
10/9
04:10 pm
qlgn
Form 8-K Qualigen Therapeutics, For: Oct 03
Medium
Report
Form 8-K Qualigen Therapeutics, For: Oct 03
9/26
05:10 pm
qlgn
Form 8-K Qualigen Therapeutics, For: Sep 23
Neutral
Report
Form 8-K Qualigen Therapeutics, For: Sep 23